Policy
Nader Pourhassan, who led CytoDyn for nearly 10 years, was convicted in December 2024 of misleading investors regarding the biotech’s investigational COVID-19 and HIV drug, which artificially inflated its share price.
FEATURED STORIES
An inconsistent boom-and-bust cycle funding environment for early-stage biotech innovations and burdensome regulation threaten the U.S.’s half-century-long dominance in the biotech sector.
Acadia Pharma’s Catherine Owen Adams is one of the founders of a group of small- to mid-cap biotechs advocating against a ‘peanut butter blanket’ approach to drug pricing for small companies.
Former European Trade Commissioner Phil Hogan and former U.S. Senator Richard Burr, speaking on a panel at the J.P. Morgan Healthcare Conference, pushed to see a larger picture beyond the Trump administration’s year of chaos and confusion.
Subscribe to BioPharm Executive
Market insights and trending stories for biopharma leaders, in your inbox every Wednesday
THE LATEST
The Food and Drug Administration is taking care of a few approvals and committee meetings ahead of the Thanksgiving holiday week. They include drugs for COPD, a pain drug, and a sublingual film formulation of a well-known drug for erectile dysfunction. Here’s a look.
Scott Gottlieb, commissioner of the Food and Drug Administration (FDA), provided an update on the agency’s Expanded Access program.
Al Qassimi, Khorfakkan, Saqr, Shaam, Fujairah, Dibba, Kuwait, Obaidullah and Kalba hospitals covered under the program
Event held in coordination with World Health Organization regional office
The Ministry of Health and Prevention (MOHAP) has announced the second phase completion of its initiative, ‘Heart Experts,’ which designates a select group of students to serve as awareness ambassadors for cardiovascular health in their schools, neighborhood and local community.
Dubai South has signed a Memorandum of Understanding (MOU) with the UAE Ministry of Health and Prevention (MOHAP) as part of its efforts to strengthen cooperation with the pharmaceutical sector and enable pharmaceutical companies to take advantage of the opportunities to operate within Dubai South.
The pharma industry began to push back against the presidential blueprint for drug prices ahead of the election. Will that continue with a now divided Congress?
Joseph Eid, head of medical at BMS, said Empliciti in combination with pomalidomide and dexamethasone has provided proof that the medication can extend the time a patient can live without the worsening of his or her disease.
Following a routine audit, the UK Medicines and Healthcare Products Regulatory Agency (MHRA) have restricted the manufacturing licence for five non-critical highly potent products supplied from the Recipharm facility located in Ashton-u-Lyne, UK.
According to the American Cancer Society, almost 601,000 people in the U.S. died of cancer in 2017. The two most common types of cancer are lung cancer and breast cancer, followed by colorectal cancer, prostate cancer and stomach cancer.